Skip to main content

Table 2 Search Strategy

From: Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop

Database

Pub Med

Ovid Medline

EMBASE

Dates searched

1/1/1990 - 12/31/2009

1/1/1990 - 12/31/2009

1990 - 2009

Search terms employed (all connected by logical "OR" function)

MeSH headings:

MeSH headings:

 
 

   Crotalid venoms/PO [poisoning]

   Crotalid venoms/PO [poisoning]

Crotalid venoms AND [intoxication OR toxicity]

 

   Crotalid venoms/TO [toxicity]

   Crotalid venoms/TO [toxicity]

Snake venoms AND [intoxication OR toxicity]

 

   Snake venoms/PO

   Snake venoms/PO

Snake bites AND [drug therapy OR therapy]

 

   Snake venoms/TO

   Snake venoms/TO

 
 

   Snake bites/DT [drug therapy]

   Snake bites/DT [drug therapy]

Viperidae

 

   Snake bites/TH [therapy]

   Snake bites/TH [therapy]

Agkistrodon

 

   Viperidae

   Viperidae

Crotalus

 

   Agkistrodon

   Agkistrodon

FabAV

 

   Crotalus

   Crotalus

Crotaline immune Fab

 

Keywords

Keywords

 
 

   CroFab

   CroFab

 
 

   Crotaline immune Fab

   Crotaline immune Fab

 

Citations retrieved

1230

1097

1711

  1. Searches were conducted on January 6, 2010 and were limited to English language and humans. After removal of 1,748 duplicate citations, 339 additional citations were excluded based on the keywords rat(s), mouse, mice, rabbit(s), cellular, in vivo, or in vitro. Hand-search of the titles and abstracts of the remaining 1,951 citations yielded 91 citations that appeared to contain original data about crotaline snake envenomation patients who were either treated with Fab antivenom or managed without antivenom. Full-text copies of these 91 articles and abstracts were obtained and made available to the project team in a computer data file. Of these, 42 articles and abstracts were identified as containing data relevant to the key questions identified in preliminary panel discussions. These 42 references were reproduced and made available during the in-person panel meeting.